Mesa Laboratories, Inc designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness.
Read More…
Industry, Sector and Symbol
Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorMedical
Phone303-987-8000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$103.14 million
Profitability
Miscellaneous
Employees366
Next Earnings Date10/30/2019 (Estimated)
OptionableNot Optionable
Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions
What is Mesa Laboratories' stock symbol?
Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."
How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?
Mesa Laboratories declared a quarterly dividend on Tuesday, July 9th. Investors of record on Friday, August 30th will be paid a dividend of $0.16 per share on Monday, September 16th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend is Thursday, August 29th. View Mesa Laboratories' Dividend History.
How were Mesa Laboratories' earnings last quarter?
Mesa Laboratories, Inc. (NASDAQ:MLAB) announced its earnings results on Monday, June, 3rd. The medical instruments supplier reported $0.34 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.08 by $0.74. The medical instruments supplier had revenue of $26.45 million for the quarter, compared to analyst estimates of $29 million. Mesa Laboratories had a return on equity of 19.67% and a net margin of 7.53%. View Mesa Laboratories' Earnings History.
When is Mesa Laboratories' next earnings date?
What is the consensus analysts' recommendation for Mesa Laboratories?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Mesa Laboratories.
Has Mesa Laboratories been receiving favorable news coverage?
Media headlines about MLAB stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Mesa Laboratories earned a coverage optimism score of -2.3 on InfoTrie's scale. They also assigned news articles about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Mesa Laboratories.
Are investors shorting Mesa Laboratories?
Mesa Laboratories saw a increase in short interest in the month of July. As of July 15th, there was short interest totalling 605,000 shares, an increase of 31.2% from the June 15th total of 461,000 shares. Based on an average trading volume of 84,700 shares, the short-interest ratio is presently 7.1 days. Approximately 17.4% of the company's stock are short sold. View Mesa Laboratories' Current Options Chain.
Who are some of Mesa Laboratories' key competitors?
Some companies that are related to Mesa Laboratories include Rudolph Technologies (RTEC), Hurco Companies (HURC), Crawford United (CRAWA), Hickok (HICKA), Clearsign Combustion (CLIR), International Isotopes (INIS), Sypris Solutions (SYPR), Electro-Sensors (ELSE), Schmitt Industries (SMIT), Winland (WELX), National Automation Services (NESV) and Universal Detection Technology (UNDT).
What other stocks do shareholders of Mesa Laboratories own?
Who are Mesa Laboratories' key executives?
Mesa Laboratories' management team includes the folowing people:
- Mr. Gary M. Owens, CEO, Pres & Director (Age 51)
- Mr. John V. Sakys, Chief Financial Officer, Chief Accounting Officer, Sec. & Treasurer (Age 50)
- Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 54)
- Ms. Helene R. Leone, Gen. Counsel
- Mr. Peter Jung, VP of Corp. Devel. & Strategy
Who are Mesa Laboratories' major shareholders?
Mesa Laboratories' stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.11%), Conestoga Capital Advisors LLC (11.60%), Price T Rowe Associates Inc. MD (6.89%), Vanguard Group Inc. (5.76%), Atlanta Capital Management Co. L L C (2.87%) and Northern Trust Corp (1.77%). Company insiders that own Mesa Laboratories stock include David M Kelly, Evan Guillemin, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc. View Institutional Ownership Trends for Mesa Laboratories.
Which major investors are selling Mesa Laboratories stock?
MLAB stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Price T Rowe Associates Inc. MD, King Luther Capital Management Corp, Atlanta Capital Management Co. L L C, Renaissance Technologies LLC, Crawford Investment Counsel Inc., Teton Advisors Inc. and Public Employees Retirement System of Ohio. Company insiders that have sold Mesa Laboratories company stock in the last year include David M Kelly, Evan Guillemin, John Bradley Schmieder, Michael T Brooks and Robert V Dwyer. View Insider Buying and Selling for Mesa Laboratories.
Which major investors are buying Mesa Laboratories stock?
MLAB stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., Kistler Tiffany Companies LLC, Bank of New York Mellon Corp, Invesco Ltd., Conestoga Capital Advisors LLC, Nuveen Asset Management LLC and Susquehanna International Group LLP. View Insider Buying and Selling for Mesa Laboratories.
How do I buy shares of Mesa Laboratories?
Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Mesa Laboratories' stock price today?
One share of MLAB stock can currently be purchased for approximately $220.50.
How big of a company is Mesa Laboratories?
Mesa Laboratories has a market capitalization of $864.36 million and generates $103.14 million in revenue each year. The medical instruments supplier earns $7.48 million in net income (profit) each year or $5.37 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.View Additional Information About Mesa Laboratories.
What is Mesa Laboratories' official website?
How can I contact Mesa Laboratories?
Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]
MarketBeat Community Rating for Mesa Laboratories (NASDAQ MLAB)
MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote "Outperform" if you believe MLAB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.
